End-of-day quote
Korea S.E.
18:00:00 2024-05-13 EDT
|
5-day change
|
1st Jan Change
|
6,500
KRW
|
-0.31%
|
|
+0.31%
|
-7.14%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
81,039
|
101,386
|
139,365
|
141,509
|
108,181
|
95,597
|
Enterprise Value (EV)
1 |
70,022
|
86,228
|
124,018
|
122,360
|
93,600
|
100,542
|
P/E ratio
|
9.22
x
|
8.04
x
|
13.8
x
|
9.88
x
|
7.83
x
|
7.68
x
|
Yield
|
1.55%
|
1.8%
|
1.23%
|
1.72%
|
2.07%
|
2.29%
|
Capitalization / Revenue
|
1.44
x
|
1.56
x
|
2.26
x
|
1.9
x
|
1.31
x
|
0.98
x
|
EV / Revenue
|
1.24
x
|
1.32
x
|
2.01
x
|
1.65
x
|
1.13
x
|
1.03
x
|
EV / EBITDA
|
5.37
x
|
4.84
x
|
8.62
x
|
6.6
x
|
5.05
x
|
5.9
x
|
EV / FCF
|
467
x
|
45.6
x
|
82.5
x
|
127
x
|
-20.9
x
|
-15.7
x
|
FCF Yield
|
0.21%
|
2.19%
|
1.21%
|
0.79%
|
-4.78%
|
-6.38%
|
Price to Book
|
1.8
x
|
1.79
x
|
2.09
x
|
1.79
x
|
1.23
x
|
1
x
|
Nbr of stocks (in thousands)
|
12,532
|
13,732
|
14,294
|
14,294
|
13,977
|
13,657
|
Reference price
2 |
6,467
|
7,383
|
9,750
|
9,900
|
7,740
|
7,000
|
Announcement Date
|
19-02-28
|
20-02-28
|
21-02-26
|
22-02-25
|
23-02-28
|
24-03-21
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
56,289
|
65,106
|
61,688
|
74,290
|
82,604
|
97,897
|
EBITDA
1 |
13,051
|
17,821
|
14,384
|
18,529
|
18,551
|
17,035
|
EBIT
1 |
10,958
|
14,668
|
11,119
|
14,968
|
14,918
|
12,757
|
Operating Margin
|
19.47%
|
22.53%
|
18.03%
|
20.15%
|
18.06%
|
13.03%
|
Earnings before Tax (EBT)
1 |
11,046
|
14,982
|
10,700
|
15,787
|
15,704
|
12,961
|
Net income
1 |
9,472
|
13,240
|
10,172
|
14,323
|
13,900
|
12,486
|
Net margin
|
16.83%
|
20.34%
|
16.49%
|
19.28%
|
16.83%
|
12.75%
|
EPS
2 |
701.0
|
917.8
|
709.0
|
1,002
|
988.0
|
911.5
|
Free Cash Flow
1 |
149.9
|
1,890
|
1,503
|
962.4
|
-4,470
|
-6,413
|
FCF margin
|
0.27%
|
2.9%
|
2.44%
|
1.3%
|
-5.41%
|
-6.55%
|
FCF Conversion (EBITDA)
|
1.15%
|
10.6%
|
10.45%
|
5.19%
|
-
|
-
|
FCF Conversion (Net income)
|
1.58%
|
14.27%
|
14.77%
|
6.72%
|
-
|
-
|
Dividend per Share
2 |
100.0
|
133.0
|
120.0
|
170.0
|
160.0
|
160.0
|
Announcement Date
|
19-02-28
|
20-02-28
|
21-02-26
|
22-02-25
|
23-02-28
|
24-03-21
|
Fiscal Period: December |
2023 Q3
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
3.041
|
Net margin
|
-
|
EPS
2 |
223.0
|
Dividend per Share
|
-
|
Announcement Date
|
23-11-14
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
4,945
|
Net Cash position
1 |
11,016
|
15,158
|
15,347
|
19,149
|
14,581
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.2903
x
|
Free Cash Flow
1 |
150
|
1,890
|
1,503
|
962
|
-4,470
|
-6,413
|
ROE (net income / shareholders' equity)
|
27.3%
|
25.3%
|
16.1%
|
19.7%
|
16.7%
|
13.5%
|
ROA (Net income/ Total Assets)
|
14.2%
|
13.4%
|
8.46%
|
10.1%
|
9.07%
|
6.92%
|
Assets
1 |
66,506
|
98,900
|
120,219
|
141,714
|
153,239
|
180,463
|
Book Value Per Share
2 |
3,589
|
4,124
|
4,654
|
5,522
|
6,294
|
6,982
|
Cash Flow per Share
2 |
815.0
|
1,005
|
1,292
|
1,403
|
362.0
|
379.0
|
Capex
1 |
1,382
|
1,001
|
566
|
5,335
|
9,248
|
2,888
|
Capex / Sales
|
2.46%
|
1.54%
|
0.92%
|
7.18%
|
11.2%
|
2.95%
|
Announcement Date
|
19-02-28
|
20-02-28
|
21-02-26
|
22-02-25
|
23-02-28
|
24-03-21
|
|
1st Jan change
|
Capi.
|
---|
| -7.14% | 65.05M | | -2.78% | 15.37B | | -37.28% | 2.92B | | -12.11% | 2.48B | | -14.23% | 1.45B | | -.--% | 1.12B | | +66.72% | 609M | | +90.77% | 499M | | +18.98% | 249M | | -2.35% | 225M |
Medical Imaging Systems
|